Benoxaprofen
CAS: 51234-28-7
Rif. 3D-BCA23428
1mg | Fuori produzione | ||
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione | ||
50mg | Fuori produzione | ||
100mg | Fuori produzione |
Informazioni sul prodotto
- (RS)-Benoxaprofen
- (±)-2-(4-Chlorophenyl)-α-methyl-5-benzoxazoleacetic acid
- 2-(2-(4-Chlorophenyl)benzo[d]oxazol-5-yl)propanoic acid
- 2-[2-(4-Chlorophenyl)-1,3-Benzoxazol-5-Yl]Propanoic Acid
- 2-[2-(4-Chlorophenyl)benzoxazol-5-yl]-propanoic acid
- 299582Q1
- 5-Benzoxazoleacetic acid, 2-(4-chlorophenyl)-α-methyl-
- Compound 90459
- Coxigon
- Lilly 90459
- Vedi altri sinonimi
- Lrcl 3794
- NSC 299582
- Opren
- Uniprofen
- dl-Benoxaprofen
Benoxaprofen is an analog of the nonsteroidal anti-inflammatory drug (NSAID) family that has been shown to have anticancer properties. It has been found to induce apoptosis in human cancer cells and inhibit tumor growth in Chinese hamsters. Benoxaprofen works by inhibiting the activity of specific kinases, which are enzymes involved in cell signaling pathways that regulate protein synthesis and cell division. This drug also inhibits the activity of other inhibitors, including oseltamivir, which is used to treat influenza infections. Benoxaprofen is excreted primarily through urine, making it a useful tool for studying the relationship between this drug and cancer cells.